BioHealth News Archive
BHI Congratulates SISU Global!
Sisu Global is a 2022 TiE50 Winner! TiE50 is TiE Silicon Valley's premier annual awards program, contested by thousands of early to mid-stage startups…
Read More
The National Institutes of Health, a Technology Transfer Wellspring · BioBuzz
The National Institutes of Health (NIH) is a critical pillar of the U.S. public health system and a beacon of guidance for healthcare best…
Read More
Linshom Medical, Inc. Closes $1.5 million Series A Round with Investment from Maryland Momentum Fund and Current Investors
Linshom is First to Deliver an Operating-Room-Quality Respiratory Profile to Patient Bedside for Continuous, Predictive Respiratory Monitoring (CPRM) Baltimore, Md. (April 27, 2022) – Linshom (“to…
Read More
Maryland Stem Cell Research Commission Announces Over $7 Million in Awards to Accelerate Cures | TEDCO
May 16, 2022 (Columbia, Md.)—The Maryland Stem Cell Research Commission announced it will grant $7,067,409 in award funding to innovative research that will strengthen…
Read More
Register for Catalyze Pre-IND Webinar on May 18th @ 12 PM ET
What is a pre-IND? Why have a pre-IND? What goes into preparing for a pre-IND? And, what documents are required? All of these questions…
Read More
Douglas Falk, CEO & Co-founder of Vita Therapeutics Visits BioTalk
Vita Therapeutics CEO & Co-founder Douglas Falk chats with Rich Bendis to discuss his career, their platforms, and moving into the University of Maryland…
Read More
Emergent BioSolutions to Acquire from Chimerix its Exclusive Worldwide Rights to TEMBEXA® (brincidofovir), the First FDA-Approved Smallpox Oral Antiviral for All Ages
GAITHERSBURG, Md., May 16, 2022 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that it has entered into a definitive agreement with…
Read More
Emmes Supports Landmark mRNA COVID-19 Vaccine Trial in Sub-Saharan Africa
ROCKVILLE, Md., May 16, 2022 /PRNewswire/ -- Emmes, a global, full-service clinical research organization (CRO) dedicated to supporting the advancement of public health and…
Read More
Sponsored Deloitte: Why now could be a great time to start preparing for an IPO | Crain’s New York Business
No question about it—2021 was a banner year for initial public offerings. Nasdaq data indicates 1,033 IPOs last year, more than double 2020’s 471.…
Read More
The Dutch company MIMETAS expanded its license to the HUB Organoid Technology to include all organs – Drug Discovery & Development
MIMETAS, a global leader in Organ-on-a-Chip models and technology and headquartered in the Netherlands (Europe), announces that it has expanded its license to the…
Read More
IndyGeneUS AI Awarded Grant Funding through QuickFire Challenge
IndyGeneUS plans to use the grant funding from Johnson & Johnson Innovation to Scale Blockchain-secured Genomic Data Marketplace and Proprietary GenēUS™ Discovery Platform WASHINGTON, May…
Read More
Another Federal Regional Cluster Funding Opportunity Emerges
By: Brian Darmody, Chief Strategy Officer, AURP: Building Communities of Innovation May 10, 2022 Sometime this September, the US Economic and Development Agency (EDA)…
Read More
QIAGEN Acquires Majority Stake in Enzymes Provider BLIRT S.A. | Business Wire
HILDEN, Germany & GERMANTOWN, Md.--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today that it has signed agreements to acquire a 96%…
Read More
Qiagen N.V. – QIAGEN acquires majority stake in enzymes provider BLIRT S.A.
HILDEN, Germany & GERMANTOWN, Md.--(BUSINESS WIRE)-- QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today that it has signed agreements to acquire a…
Read More
Cartesian Therapeutics to Present Late-Breaking Data from Phase 1/2a Trial of RNA CAR T-cell Therapy in Patients with Generalized Myasthenia Gravis
- Data Presentation Today at 14th Myasthenia Gravis Foundation of America International Conference on Myasthenia and Related Disorders in Miami - GAITHERSBURG, Md., May 10, 2022 /PRNewswire/ --…
Read More